DELCATH SYS INC (DCTH) — insider trading
Health Care · NASDAQ
DELCATH SYS INC (DCTH) has 17 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 17 (latest 2026-05-13).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Aharon Gil | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-05-13 | SALAMON STEVEN A J | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-05-13 | CZEREPAK ELIZABETH | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Martell Bridget A | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Sylvester John Richard | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-03-06 | Pennell Sandra | Officer (Chief Financial Officer) | Open-market purchase | 5,533 | $9.04 | $50.0K | Form 4 |
| 2026-03-02 | MICHEL GERARD J | Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | 11,200 | $8.96 | $100.3K | Form 4 |
| 2026-02-17 | Rook Martha S. | Officer (CHIEF OPERATING OFFICER) | Grant / award / vesting (derivative) | 28,250 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Rook Martha S. | Officer (CHIEF OPERATING OFFICER) | Grant / award / vesting (derivative) | 56,500 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Vukovic Vojo | Officer (CHIEF MEDICAL OFFICER) | Grant / award / vesting (derivative) | 28,250 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Vukovic Vojo | Officer (CHIEF MEDICAL OFFICER) | Grant / award / vesting (derivative) | 56,500 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Pennell Sandra | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 28,250 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Pennell Sandra | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 56,500 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Muir Kevin | Officer (GM INTERVENTIONAL ONCOLOGY) | Grant / award / vesting (derivative) | 28,250 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Muir Kevin | Officer (GM INTERVENTIONAL ONCOLOGY) | Grant / award / vesting (derivative) | 56,500 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Hoffman David L. | Officer (GEN'L COUNSEL, CCO & SECY) | Grant / award / vesting (derivative) | 28,250 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Hoffman David L. | Officer (GEN'L COUNSEL, CCO & SECY) | Grant / award / vesting (derivative) | 56,500 | $0.00 | $0 | Form 4 |
Ask the chat about DCTH's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: DELCATH SYS INC (DCTH).
Last updated 2026-05-13 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.